Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (17)
  • Open Access

    ARTICLE

    The new gold standard for surgical management of BPH: an institutional experience with 1000 HoLEPs

    Yash B. Shah1, Brian H. Im1, Aaron R. Hochberg1, Elliott P. Freudenburg2, James Jiang2, Bruce M. Gao2, Mihir S. Shah1, Akhil K. Das2,*

    Canadian Journal of Urology, Vol.32, No.1, pp. 15-19, 2025, DOI:10.32604/cju.2025.064708 - 20 March 2025

    Abstract Introduction: Holmium Laser Enucleation of the Prostate (HoLEP) is a size-independent, endoscopic management option for benign prostatic hyperplasia (BPH). HoLEP offers a distinct advantage for patients who are at high-risk for bleeding whilst preserving prostatic tissue for pathology analysis, unlike photoselective vaporization. Further, HoLEP avoids the need for cystotomy, unlike simple open and robotic prostatectomy, by using intravesical morcellation. We report our experience with the first 1000 HoLEP procedures at our institution. Materials and Methods: We performed a retrospective review of all HoLEP procedures performed at our institution from 2013–2021 to capture patient demographics, procedure details,… More >

  • Open Access

    RESIDENT’S CORNER

    Holmium laser enucleation of the prostate for a case of transition zone prostate cancer

    Michelle K. Li, Orlando Diaz, Jonathan E. Katz

    Canadian Journal of Urology, Vol.31, No.2, pp. 11861-11863, 2024

    Abstract Standard treatment approaches for localized prostate cancer remain limited to active surveillance, radiotherapy, and radical prostatectomy. We present a case of transition zone prostate cancer that was treated with holmium laser enucleation of the prostate, a procedure that is normally reserved for the management of benign prostatic hyperplasia. More >

  • Open Access

    HOW I DO IT

    How I Do It: Teaching holmium laser enucleation of the prostate (HoLEP)

    Agustín Pérez-Londoño, Alejandro Abello, Boris Gershman, Ruslan Korets

    Canadian Journal of Urology, Vol.31, No.2, pp. 11848-11853, 2024

    Abstract Holmium laser enucleation of the prostate (HoLEP) is considered a size-independent technique to treat benign prostatic hyperplasia. This safe and effective procedure is increasingly being adopted in urology training programs worldwide, yet limited teaching strategies have been described. Endoscopic handling during HoLEP allows for a simultaneous interaction between the surgeon and trainee, facilitating a guided teaching strategy with increasing difficulty as experience grows. In this article, we describe our stepwise approach for teaching HoLEP as part of a structured surgical training curriculum. We also evaluate the association of our method with intraoperative efficiency parameters and More >

  • Open Access

    HOW I DO IT

    How I Do It: Holmium laser cystolitholapaxy and enucleation of the prostate for benign prostatic hyperplasia

    Bruce M. Gao, Seyedamirvala Saadat, Edward J. H. Choi, James Jiang, Akhil K. Das

    Canadian Journal of Urology, Vol.31, No.3, pp. 11904-11907, 2024

    Abstract Holmium enucleation of the prostate (HoLEP) is a gold standard, size-independent surgical treatment for benign prostatic hyperplasia (BPH) distinguished for its efficacy in tissue removal, shorter catheterization durations, lower transfusion rates, and decreased hospital stays when compared to transurethral resection of the prostate (TURP). The objective of this article is to demonstrate the step-by-step procedure of holmium laser cystolitholapaxy and enucleation of the prostate for BPH, emphasizing a top-down modified two-lobe technique with early apical release which enhances visualization and irrigation flow during the enucleation process. More >

  • Open Access

    ARTICLE

    Travel characteristics and outcomes for patients seeking HoLEP

    Gopal Narang, Jonathan Moore, Haidar Abdul-Muhsin, Scott Cheney, Mitchell Humphreys

    Canadian Journal of Urology, Vol.29, No.2, pp. 11067-11074, 2022

    Abstract Introduction: Holmium laser enucleation of the prostate (HoLEP) is an effective but underutilized option for the surgical management of benign prostatic hyperplasia (BPH). With low adoption, questions arise surrounding patients access to care. It is unclear whether patients undergoing HoLEP are local or specifically seek care from afar. We looked to determine the proportion of patients who traveled out-of-state for HoLEP treatment and the impact of travel on peri and postoperative metrics.
    Materials and methods: We performed a retrospective cohort study evaluating patients that underwent HoLEP at a single institution from 2007-2019. Patient demographic, perioperative data, postoperative… More >

  • Open Access

    ARTICLE

    Aquablation with subsequent selective bipolar cauterization versus holmium laser enucleation of the prostate (HoLEP) with regard to perioperative bleeding

    Simon Gloger1, Leon Schueller1, Laszlo Paulics1, Thorsten Bach2, Burkhard Ubrig1

    Canadian Journal of Urology, Vol.28, No.3, pp. 10685-10690, 2021

    Abstract Introduction: To compare the surgical methods of Aquablation followed by selective hemostasis by bipolar cauterization with holmium laser enucleation of the prostate (HoLEP) with regard to the risk of perioperative bleeding complications.
    Materials and methods: A retrospective comparison was carried out on a total of 382 patients who had undergone either Aquablation (n = 167) or HoLEP (n = 215) at our hospital between April 2018 and July 2020. The following were studied: Hb loss, the need for packed red blood cell transfusions, and surgical revisions due to bleeding from the prostatic fossa.
    Results: Transfusions were not necessary… More >

  • Open Access

    ARTICLE

    Incidental prostate cancer at holmium laser enucleation of prostate

    Asaf Shvero1,2, Seth Teplitsky3, Edward Kloniecke1, Akhil K. Das1

    Canadian Journal of Urology, Vol.28, No.6, pp. 10900-10906, 2021

    Abstract Introduction: The purpose of this study was to describe the current incidence, risk factors, and management of incidental diagnosis of prostate cancer (iPCa) among patients who underwent holmium laser enucleation of prostate (HoLEP) and have no history of prostate cancer.
    Materials and methods: We conducted a retrospective review of all patients who underwent HoLEP in our institution between 2013-2020. All patients were offered a PSA screening according to the latest guidelines. We gathered demographic data, perioperative information, and pathologic evaluation. For patients diagnosed with iPCa, we gathered work up, management, and oncologic outcome. We then conducted a… More >

  • Open Access

    EDITORIAL

    Spécificités des Tumeurs de la Sphère Ophtalmique: Utilité d’un Réseau National

    Laurence Desjardins*

    Oncologie, Vol.22, No.4, pp. 189-194, 2020, DOI:10.32604/oncologie.2020.012377

    Abstract Nous décrivons les principales tumeurs malignes intraoculaires, les tumeurs conjonctivales et citons également quelques tumeurs orbitopalpébrales. Les tumeurs malignes primitives intraoculaires sont le rétinoblastome chez l’enfant et le mélanome uvéal chez l’adulte. Le mélanome uvéal métastase essentiellement au niveau du foie ce qui justifie une surveillance hépatique régulière. Les métastases peuvent survenir dans l’uvée également le plus souvent l’uvée postérieure ou choroïde et sont plus fréquentes après cancer du sein ou du poumon. Les tumeurs conjonctivales peuvent être épithéliales (papillome bénins et carcinome épidermoïdes malins in situ ou invasifs) ou mélanocytaires (nævi bénins et mélanome More >

  • Open Access

    ARTICLE

    A retrospective comparison of diode to holmium for laser enucleation of the prostate

    Akhil K. Das*, Seth Teplitsky*, Alex Uhr, Joon Yau Leong, Victor Kucherov, Patrick J. Shenot

    Canadian Journal of Urology, Vol.26, No.4, pp. 9836-9842, 2019

    Abstract Introduction: Holmium endoscopic laser enucleation of the prostate (HoLEP) is a well-established alternative to traditional transurethral resection and open prostatectomy for the treatment of benign prostatic hyperplasia (BPH). We investigate the 1470 nm diode laser for enucleation as an alternative to HoLEP. The safety, efficacy, and initial outcomes of diode enucleation of the prostate (DiLEP), when compared to HoLEP, were examined.
    Materials and methods: We reviewed records of 50 patients who underwent DiLEP between 2012 and 2015 and matched them with 50 HoLEP patients during the same time period. Objective evaluation of efficacy was determined by comparing… More >

  • Open Access

    COMMENTARY

    Holmium laser: not just the tool for BPH enucleation

    Kevin C. Zorn

    Canadian Journal of Urology, Vol.23, No.4, pp. 8362-8363, 2016

    Abstract This article has no abstract. More >

Displaying 1-10 on page 1 of 17. Per Page